UBS Group’s Evo Acquisition Corp. Class A Common Stock EVOJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-3,044
Closed -$32.7K 11174
2022
Q4
$32.7K Buy
3,044
+1,213
+66% +$12.1K ﹤0.01% 7149
2022
Q3
$18K Buy
1,831
+290
+19% +$2.85K ﹤0.01% 7561
2022
Q2
$15K Hold
1,541
﹤0.01% 7346
2022
Q1
$15K Buy
+1,541
New +$15K ﹤0.01% 7876
2021
Q4
Sell
-1,200
Closed -$12K 11027
2021
Q3
$12K Sell
1,200
-700
-37% -$6.79K ﹤0.01% 7824
2021
Q2
$18K Buy
+1,900
New +$18.5K ﹤0.01% 7469

Other funds holding EVOJ

UBS Group's EVOJ Position: Q1 2023 in Review

UBS Group sold out of Evo Acquisition Corp. Class A Common Stock (EVOJ) in Q1 2023, closing a stake of 3,044 shares — an estimated $32.7K sold.

UBS Group first reported a position in EVOJ in Q2 2021 and held it in 6 quarters. The position peaked at $32.7K in Q4 2022. 5 funds tracked by Wall St. Rank hold EVOJ as of Q1 2023.

  • UBS Group reported no remaining Evo Acquisition Corp. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • UBS Group sold 3,044 Evo Acquisition Corp. Class A Common Stock shares in Q1 2023, an estimated $32.7K.
  • UBS Group first reported a position in Evo Acquisition Corp. Class A Common Stock in Q2 2021 and held it in 6 quarters.
  • UBS Group's Evo Acquisition Corp. Class A Common Stock position peaked at $32.7K in Q4 2022.
  • 5 funds tracked by Wall St. Rank held Evo Acquisition Corp. Class A Common Stock as of Q1 2023.

Based on UBS Group's 13F filing for Q1 2023, filed 12 May 2023.